# Evaluation of NB1 Bone Graft Following Lumbar Interbody Arthrodesis

> **NCT03810573** · NA · RECRUITING · sponsor: **Bone Biologics Corp** · enrollment: 30 (estimated)

## Conditions studied

- Degenerative Disc Disease
- Spondylolisthesis

## Interventions

- **DEVICE:** NB1

## Key facts

- **NCT ID:** NCT03810573
- **Lead sponsor:** Bone Biologics Corp
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-03-01
- **Primary completion:** 2025-06-01
- **Final completion:** 2026-06-01
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2024-03-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03810573

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03810573, "Evaluation of NB1 Bone Graft Following Lumbar Interbody Arthrodesis". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT03810573. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*